Pulsenmore (XTAE:PULS) Change In Receivables : ₪-2.81 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pulsenmore Change In Receivables?

Pulsenmore's change in receivables for the quarter that ended in Dec. 2024 was ₪-0.71 Mil. It means Pulsenmore's Accounts Receivable increased by ₪0.71 Mil from Jun. 2024 to Dec. 2024 .

Pulsenmore's change in receivables for the fiscal year that ended in Dec. 2024 was ₪-2.81 Mil. It means Pulsenmore's Accounts Receivable increased by ₪2.81 Mil from Dec. 2023 to Dec. 2024 .

Pulsenmore's Accounts Receivable for the quarter that ended in Dec. 2024 was ₪3.91 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Pulsenmore's Days Sales Outstanding for the six months ended in Dec. 2024 was 134.32.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Pulsenmore's liquidation value for the six months ended in Dec. 2024 was ₪73.56 Mil.

Pulsenmore Change In Receivables Historical Data

The historical data trend for Pulsenmore's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsenmore Change In Receivables Chart

Pulsenmore Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

0.19

-7.12

-6.63

10.43

-2.81

Pulsenmore Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial						-9.38	8.96	1.47	-2.10	-0.71

Pulsenmore Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-2.81 Mil.

Pulsenmore (XTAE:PULS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Pulsenmore's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3.909	/	5.311	*	91
=	134.32

2. In Ben Graham's calculation of liquidation value, Pulsenmore's accounts receivable are only considered to be worth 75% of book value:

Pulsenmore's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	104.023	-	44.939	+	0.75 * 3.909	+	0.5 * 23.092
=	73.56

Pulsenmore Change In Receivables Related Terms

Thank you for viewing the detailed overview of Pulsenmore's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulsenmore Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsenmore Ltd (XTAE:PULS) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Omarim 8, Omar, ISR, 8496500

Website

https://www.pulsenmore.com

Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.